Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles can help wounds heal faster and this knowledge could be used to treat chronic skin ulcers, with a potential use of a special stem cell hydrogel to enhance healing.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Different hair protein amounts change the strength of keratin/chitosan gels, useful for making predictable tissue engineering materials.

Micrografts improve hair density and thickness without side effects.

A special hydrogel helps heal skin without scars and regrows hair.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.